These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10870400)

  • 21. Androgenetic alopecia: overview.
    Sawaya ME
    J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S14-20. PubMed ID: 11749885
    [No Abstract]   [Full Text] [Related]  

  • 22. Finasteride increases anagen hair in men with androgenetic alopecia.
    Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
    Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
    Lin JH; Chen WC
    Kaohsiung J Med Sci; 2002 Aug; 18(8):379-85. PubMed ID: 12476680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of finasteride 1 mg in the treatment of androgenetic alopecia in men.
    Olsen EA
    Exp Dermatol; 1999 Aug; 8(4):302-3. PubMed ID: 10439233
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).
    Shapiro J; Kaufman KD
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):20-3. PubMed ID: 12894990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human genetics. Hair apparent.
    Davies K
    Nature; 1998 Feb; 391(6667):537, 539. PubMed ID: 9468131
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    Finasteride Male Pattern Hair Loss Study Group
    Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Male pattern baldness.
    Hogan DJ; Chamberlain M
    South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
    Walsh DS; Dunn CL; James WD
    Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines for the management of androgenetic alopecia (2010).
    Tsuboi R; Itami S; Inui S; Ueki R; Katsuoka K; Kurata S; Kono T; Saito N; Manabe M; Yamazaki M;
    J Dermatol; 2012 Feb; 39(2):113-20. PubMed ID: 22171995
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythema annulare centrifugum secondary to treatment with finasteride.
    Al Hammadi A; Asai Y; Patt ML; Sasseville D
    J Drugs Dermatol; 2007 Apr; 6(4):460-3. PubMed ID: 17668547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Finasteride induced depression: a prospective study.
    Rahimi-Ardabili B; Pourandarjani R; Habibollahi P; Mualeki A
    BMC Clin Pharmacol; 2006 Oct; 6():7. PubMed ID: 17026771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hair loss.
    Patel JC
    Indian J Med Sci; 2000 Mar; 54(3):106-9. PubMed ID: 11227614
    [No Abstract]   [Full Text] [Related]  

  • 34. Depression circumstantially related to the administration of finasteride for androgenetic alopecia.
    Altomare G; Capella GL
    J Dermatol; 2002 Oct; 29(10):665-9. PubMed ID: 12433001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients.
    Gonzalez ME; Cantatore-Francis J; Orlow SJ
    Br J Dermatol; 2010 Aug; 163(2):378-85. PubMed ID: 20346026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Finasteride--an update and review.
    Cather JC; Lane D; Heaphy MR; Nelson BR
    Cutis; 1999 Sep; 64(3):167-72. PubMed ID: 10500917
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A woman with iatrogenic androgenetic alopecia responding to finasteride.
    Hong JB; Chiu HC; Chan JY; Chen RJ; Lin SJ
    Br J Dermatol; 2007 Apr; 156(4):754-5. PubMed ID: 17263815
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A; Takeda A
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of insulin-like growth factor 1 in follicular dermal papillae correlates with therapeutic efficacy of finasteride in androgenetic alopecia.
    Tang L; Bernardo O; Bolduc C; Lui H; Madani S; Shapiro J
    J Am Acad Dermatol; 2003 Aug; 49(2):229-33. PubMed ID: 12894070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.